303: A new obesity startup, an acquisition gone wrong, & the future of Teledoc
The Readout Loud
00:00
Exploring Matera's Drug Development Strategy and Clinical Trial Approach
Exploring Matera's movement of a drug candidate to clinical trials, the chapter highlights the necessity of head-to-head studies with current obesity drugs. It stresses the importance of rigorous evaluation for investor confidence, focusing on enhancing drug efficacy and reducing side effects in the pharmaceutical industry.
Transcript
Play full episode
